Viewing Study NCT00306566


Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-02-02 @ 7:16 PM
Study NCT ID: NCT00306566
Status: COMPLETED
Last Update Posted: 2007-09-20
First Post: 2006-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients
Sponsor: Cytos Biotechnology AG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module